The United States Pharmacopeia today notified stakeholders that it is postponing the official effective dates of several new and revised standards pertaining to pharmaceutical handling until further notice while it reviews appeals to the standards. Those standards include general chapters <795> (Pharmaceutical Compounding – Nonsterile Preparations), <797> (Pharmaceutical Compounding – Sterile Preparations), and <825> (Radiopharmaceuticals – Preparation, Compounding, Dispensing, and Repackaging). In addition, due to the pending appeals, USP new general chapter <800> (Hazardous Drugs Handling in Healthcare Settings) will remain official, but only informational and will not be applicable until the appeals process is complete. The AHA in November 2018 urged USP to delay the official dates of both USP <797> and <800> due to expedited implementation and compliance concerns.
The Centers for Disease Control and Prevention Friday released an update to its 1998 guidelines to prevent and control infection in the health care workplace,…
The House Energy and Commerce Committee last night approved a revised version of the Lower Prescription Drug Costs Now Act.
The Food and Drug Administration approved a record high 1,171 generic drugs in fiscal year 2019, the agency said today.
In this AHA Stat blog, Robyn Begley, AHA senior vice president and CEO of the American Organization for Nursing Leadership, discusses how hiring and empowering…
The AHA and six other organizations today submitted comments to the Drug Enforcement Administration on its proposed rule regarding controlled substances quotas.
Insights and Analysis
The University Medical Center of El Paso treated 15 victims after a shooting at a nearby store in August. Staff credit training for their quick and calm…